ATE346611T1 - Verbesserte dns impfstoffe für rinder-herpes virus 1 - Google Patents

Verbesserte dns impfstoffe für rinder-herpes virus 1

Info

Publication number
ATE346611T1
ATE346611T1 AT01907651T AT01907651T ATE346611T1 AT E346611 T1 ATE346611 T1 AT E346611T1 AT 01907651 T AT01907651 T AT 01907651T AT 01907651 T AT01907651 T AT 01907651T AT E346611 T1 ATE346611 T1 AT E346611T1
Authority
AT
Austria
Prior art keywords
herpes virus
dna vaccines
improved dna
bovine herpes
bovine
Prior art date
Application number
AT01907651T
Other languages
English (en)
Inventor
Jean-Christophe Franc Audonnet
Laurent Bernard Fischer
Simona Barzu-Le-Roux
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Sas filed Critical Merial Sas
Application granted granted Critical
Publication of ATE346611T1 publication Critical patent/ATE346611T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT01907651T 2000-01-21 2001-01-19 Verbesserte dns impfstoffe für rinder-herpes virus 1 ATE346611T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0000798A FR2804028B1 (fr) 2000-01-21 2000-01-21 Vaccins adn ameliores pour animaux de rente

Publications (1)

Publication Number Publication Date
ATE346611T1 true ATE346611T1 (de) 2006-12-15

Family

ID=8846183

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01907651T ATE346611T1 (de) 2000-01-21 2001-01-19 Verbesserte dns impfstoffe für rinder-herpes virus 1

Country Status (21)

Country Link
EP (1) EP1248650B1 (de)
JP (1) JP2004500375A (de)
KR (1) KR100820893B1 (de)
CN (2) CN1404398B (de)
AR (1) AR027926A1 (de)
AT (1) ATE346611T1 (de)
AU (1) AU783865B2 (de)
BR (2) BRPI0107767B1 (de)
CA (1) CA2398229C (de)
CY (1) CY1107627T1 (de)
DE (1) DE60124862T2 (de)
DK (1) DK1248650T3 (de)
ES (1) ES2277913T3 (de)
FR (1) FR2804028B1 (de)
HU (1) HU229597B1 (de)
MX (1) MXPA02007110A (de)
NZ (1) NZ520270A (de)
PL (1) PL209304B1 (de)
PT (1) PT1248650E (de)
WO (1) WO2001052888A2 (de)
ZA (1) ZA200205698B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
US7078388B2 (en) 2000-01-21 2006-07-18 Merial DNA vaccines for farm animals, in particular bovines and porcines
ES2429338T3 (es) 2002-12-23 2013-11-14 Vical Incorporated Vacuna basada en polinucleótidos optimizados por codones contra infección por citomegalovirus humano
CA2515978A1 (en) * 2003-02-19 2004-09-02 Merial Limited Vaccination or immunization using a prime-boost regimen against bhv-1
ES2417019T3 (es) 2003-11-13 2013-08-05 University Of Georgia Research Foundation, Inc. Procedimiento de caracterización del virus de la enfermedad de la bursitis infecciosa
CU23544A1 (es) 2006-02-28 2010-06-17 Ct Ingenieria Genetica Biotech Antígenos vacunales quiméricos contra el virus de la peste porcina clásica
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
RU2585961C9 (ru) * 2009-05-22 2016-12-27 Дженосеа Биосайенсиз Инк. Вакцины против вируса простого герпеса 2 типа: композиции и способы запуска иммунного ответа
JP2014500875A (ja) * 2010-11-19 2014-01-16 ベイジン カイン テクノロジー シェア−ホールディング シーオー．， エルティーディー． Ｂ型肝炎の予防及び治療のためのｄｎａワクチン組成物
CN112034169A (zh) * 2020-08-27 2020-12-04 华威特（江苏）生物制药有限公司 用于检测牛病毒性腹泻病毒1型的直接免疫荧光试剂及其试剂盒

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4662393A (en) * 1992-07-08 1994-01-31 Schering Corporation Use of gm-csf as a vaccine adjuvant
EP1624068A1 (de) * 1993-06-01 2006-02-08 Life Technologies Inc. Genetische Impfung mit kationischen Lipidstoffen
US5658785A (en) * 1994-06-06 1997-08-19 Children's Hospital, Inc. Adeno-associated virus materials and methods
AU705595B2 (en) * 1994-09-09 1999-05-27 Neurocrine Biosciences, Incorporated Interleukin-1 type 3 receptors
US5736524A (en) * 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5719131A (en) * 1994-12-09 1998-02-17 Genzyme Corporation Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules
EP0826063A1 (de) * 1995-04-25 1998-03-04 Vical Incorporated Einzelfläschehene formulierungen von dna (lipid-komplexen)
AU5799996A (en) * 1995-05-26 1996-12-11 Cell Genesys, Inc. Delivery vehicles comprising stable lipid/nucleic acid compl exes
FR2751224B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
FR2751229B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
FR2751228B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique
AU1987197A (en) * 1997-03-10 1998-09-29 Heather Lynn Davis Gene delivery to mucosal epithelium for immunization or therapeutic purpose
AUPO856097A0 (en) * 1997-08-14 1997-09-04 Commonwealth Scientific And Industrial Research Organisation Vector
US6943152B1 (en) * 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
CA2375320C (en) * 1999-06-10 2013-02-19 Merial Dna vaccines for pets or for animals used in sports

Also Published As

Publication number Publication date
CA2398229A1 (en) 2001-07-26
JP2004500375A (ja) 2004-01-08
KR100820893B1 (ko) 2008-04-10
HUP0203974A3 (en) 2004-07-28
HU229597B1 (en) 2014-02-28
PL356554A1 (en) 2004-06-28
WO2001052888A3 (fr) 2001-12-20
NZ520270A (en) 2004-08-27
DE60124862T2 (de) 2007-07-05
PL209304B1 (pl) 2011-08-31
CN1404398B (zh) 2012-05-02
FR2804028A1 (fr) 2001-07-27
AU3556601A (en) 2001-07-31
MXPA02007110A (es) 2003-01-28
KR20020084093A (ko) 2002-11-04
CN101554480A (zh) 2009-10-14
CY1107627T1 (el) 2013-04-18
AR027926A1 (es) 2003-04-16
PT1248650E (pt) 2007-02-28
BRPI0107767B1 (pt) 2017-10-24
DK1248650T3 (da) 2007-04-16
ZA200205698B (en) 2003-09-29
HUP0203974A2 (hu) 2003-03-28
EP1248650A2 (de) 2002-10-16
CN1404398A (zh) 2003-03-19
DE60124862D1 (de) 2007-01-11
AU783865B2 (en) 2005-12-15
FR2804028B1 (fr) 2004-06-04
CA2398229C (en) 2012-05-15
EP1248650B1 (de) 2006-11-29
BR0107767A (pt) 2002-11-12
ES2277913T3 (es) 2007-08-01
WO2001052888A2 (fr) 2001-07-26

Similar Documents

Publication Publication Date Title
EE200200158A (et) Immunostimulatoorsed nukleiinhapped
NO20004758D0 (no) Vaksinesammensetning
ATE490327T1 (de) Impfstoffzusammensetzung
NO20014323L (no) Vaksine
DK0870508T3 (da) Influenzavaccine
NO20003302L (no) Vaksine
DE69933200D1 (de) Kombinierte impfstoffzusammensetzungen
GB2337755B (en) Virus vaccine
NO20006191D0 (no) Vaksine
DE60114935T2 (de) Individuell anpassbare universal-daumenverbandsschiene
DE60002650D1 (de) Öladjuvierter Impfstoff
NO20020763L (no) Vaksine
FR2776928B1 (fr) Vaccins adn adjuves
ATE346611T1 (de) Verbesserte dns impfstoffe für rinder-herpes virus 1
IS5694A (is) Bóluefni
ATE295182T1 (de) Zusammensetzungen zur immunverstärkung von impfstoffen
DE69820434D1 (de) Eingebetteter luftentferner
IS6184A (is) Bóluefni gegn ISA veiru
ITMI981384A1 (it) Vaccino per hiv
IT1317533B1 (it) Trasportatore aereo per segnature
GB9826647D0 (en) DNA vaccines
FI4197U1 (fi) Puhalluslaite
NO20002213L (no) Babesia vaksine
WO2002008390A3 (en) Bovine wasting syndrome vaccine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1248650

Country of ref document: EP